by
Gus Iversen, Editor in Chief | April 16, 2024
After more than 17 years with the company, GE HealthCare's imaging CEO is moving on to something new.
Jan Makela's resignation, announced in an SEC filing, indicated that he will be taking on a CEO position with a company that is not in competition with GE HealthCare:
On April 9, 2024, Jan Makela, chief executive officer, Imaging, notified GE HealthCare Technologies Inc. (the “Company”) that he will be resigning from his role at the Company to become the chief executive officer of a private company that is not one of the Company’s competitors. The Company will evaluate internal and external candidates to fill the chief executive officer, Imaging role. Mr. Makela’s last day at the Company will be July 8, 2024.
Makela became president and CEO of GE HealthCare Imaging in February of 2020. In that role, he oversaw technologies and services across MR, CT, PET, nuclear medicine, X-ray, women’s health, interventional, surgery, imaging analytics, and software. In 2022 he
wrote an article for HCB News discussing how deep learning was poised to transform imaging.
Prior to that, he served as president and CEO of GE HealthCare global services from 2017 to early 2020, where he oversaw the global development and execution of GE HealthCare’s service solutions and operations around the globe.
He joined GE Capital in 2000 and moved to GE Healthcare in 2007 to lead the diagnostic imaging services business across Northern Europe. He later served as COO for the European region. From 2013, Makela worked in GE HealthCare’s Life Sciences business as the GM of its bioprocess business, and previously as GM of Core Imaging (now called PDx).
Makela's career began in engineering and production management with M&M/Mars Inc., followed by leadership roles at A.T. Kearney management consultants before joining GE. He has a master’s degree in engineering from the University of Cambridge.
